Estimated reading time: 0 minutes, 31 seconds

Russian Supreme Court Denies Gilead’s Patent Lawsuit Over Anti-COVID Drug  

Russia’s Supreme Court rejected a lawsuit filed by Gilead Sciences, a U.S. biotech firm, after the Russian government allowed another company to produce Gilead’s anti-COVID-19 drug named remdesivir. So reports Reuters.

covid 4948866 640smallPharmasyntez, the Russian company, has been given a “compulsory license” to make the drug for one year without the permission of Gilead. “The government said in a decree at the time that the move was in the interests of Russia’s own security,” according to the article. “According to the decree, Russia had to pay compensation to the drug’s patent-holder. The amount was not specified.”

Read the full article from Reuters.

Read 235 times
Rate this item
(0 votes)

Visit other PMG Sites:

click me
PMG360 is committed to protecting the privacy of the personal data we collect from our subscribers/agents/customers/exhibitors and sponsors. On May 25th, the European's GDPR policy will be enforced. Nothing is changing about your current settings or how your information is processed, however, we have made a few changes. We have updated our Privacy Policy and Cookie Policy to make it easier for you to understand what information we collect, how and why we collect it.